Compound medicine for treating coronary heart disease and angina pectoris and its preparing process

A technology for angina pectoris and coronary heart disease, applied in the field of traditional Chinese medicine, can solve the problems of many formulas, difficult quality control, complicated preparation process, etc.

Inactive Publication Date: 2006-02-22
SHANDONG UNIV OF TRADITIONAL CHINESE MEDICINE
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Generally, there are many raw material formulas, complex preparation process,

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0045] The compound medicine for the treatment of coronary heart disease and angina pectoris of the present embodiment, get Radix Astragali 4kg respectively, Radix Angelicae Sinensis 2kg, Cinnamon Twig 1.2kg, Ginkgo biloba extract 133g, Gynostemma pentaphyllum extract 133g, prepare according to the following method:

[0046] Cinnamon twigs were crushed into coarse powder, 10 times of water was added to extract the volatile oil for 4 hours, the volatile oil was collected, the liquid was filtered to obtain liquid A, and the dregs of the cinnamon sticks were retained.

[0047] Combine astragalus, angelica and cinnamon twigs, add 10 times of water and decoct twice for 4 hours each time, filter, and combine decoctions to obtain liquid B.

[0048] Combine the above medicinal liquids A and B, dry under reduced pressure to obtain a dry extract, and pulverize to obtain medicinal powder A.

[0049] Take an appropriate amount of β-cyclodextrin, add 2 times the amount of 20% ethanol, grin...

Embodiment 2

[0053] The compound medicine for the treatment of coronary heart disease and angina pectoris of the present embodiment, get Radix Astragali 3kg respectively, Radix Angelicae Sinensis 3kg, Cinnamon Twig 1.5kg, Ginkgo biloba extract 160g, Gynostemma pentaphyllum extract 80g, prepare according to the following method:

[0054] Cinnamon twigs were crushed into coarse powder, 10 times of water was added to extract the volatile oil for 4 hours, the volatile oil was collected, the liquid was filtered to obtain liquid A, and the dregs of the cinnamon sticks were retained.

[0055] Combine astragalus, angelica and cinnamon twigs, add 10 times of water and decoct twice for 4 hours each time, filter, and combine decoctions to obtain liquid B.

[0056] Combine the above medicinal liquids A and B, dry under reduced pressure to obtain a dry extract, and pulverize to obtain medicinal powder A.

[0057] Take an appropriate amount of β-cyclodextrin, add 2 times the amount of 20% ethanol, grind...

Embodiment 3

[0061] The compound medicine for the treatment of coronary heart disease and angina pectoris of the present embodiment takes 1.6g of astragalus, 0.6g of angelica, 0.3g of cassia twig, 0.47g of ginkgo biloba extract, and 0.47g of gynostemma pentaphyllum extract.

[0062] Astragalus, angelica, and cassia twigs are ultrafinely crushed, mixed with ginkgo biloba extract, Gynostemma pentaphyllum extract, and appropriate amount of auxiliary materials, thoroughly mixed, packed into No. 1 capsules, a total of 12 capsules.

[0063] Usage and dosage: Take orally, three times a day, 4 capsules each time.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a compound medicine for treating coronary heart disease and angina pectoris and its preparing process, wherein the compound medicament comprises astragalus root, Chinese angelica root, cassia twig, ginkgo leaves extract and gynostemma pentaphylla extract as the principal raw materials.

Description

(1) Technical field [0001] The invention relates to a compound medicine for treating coronary heart disease and angina pectoris and a preparation method thereof, belonging to the technical field of traditional Chinese medicines. (2) Background technology [0002] Coronary heart disease is short for coronary heart disease. It is a kind of myocardial ischemia hypoxia or necrosis caused by coronary circulatory disorder due to fixed (atherosclerosis) or dynamic (vasospasm) stenosis or obstruction, which causes the imbalance between myocardial oxygen supply and demand. A heart disease, also known as ischemic heart disease. The incidence of coronary heart disease increases with age, and the degree also increases with age. According to data, starting from the age of 40, the prevalence rate of coronary heart disease will double for every 10 years. After the age of 50 for men and 60 for women, coronary arteriosclerosis develops rapidly, and the risk of myocardial infarction also i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/54A61P9/10
Inventor 刘桂荣牛余珍
Owner SHANDONG UNIV OF TRADITIONAL CHINESE MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap